Raia Drogasil S.A. RADLY
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.51B | 8.09B | 7.67B | 7.16B | 6.89B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.51B | 8.09B | 7.67B | 7.16B | 6.89B |
| Cost of Revenue | 5.86B | 5.63B | 5.37B | 5.00B | 4.81B |
| Gross Profit | 2.65B | 2.47B | 2.30B | 2.16B | 2.08B |
| SG&A Expenses | 2.08B | 1.95B | 1.83B | 1.73B | 1.68B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 37.76M | 36.78M | -4.34M | -4.34M | -4.34M |
| Total Operating Expenses | 7.98B | 7.61B | 7.19B | 6.73B | 6.48B |
| Operating Income | 525.87M | 482.88M | 478.37M | 430.31M | 410.85M |
| Income Before Tax | 285.21M | 246.73M | 250.92M | 243.05M | 222.56M |
| Income Tax Expenses | 36.25M | 22.97M | 30.81M | 16.82M | 19.95M |
| Earnings from Continuing Operations | 248.95 | 223.77 | 220.11 | 226.23 | 202.61 |
| Earnings from Discontinued Operations | 3.86M | 12.58M | 14.25M | 14.25M | 14.25M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.25M | -331.10K | -521.10K | -3.16M | -2.49M |
| Net Income | 254.06M | 236.02M | 233.84M | 237.32M | 214.37M |
| EBIT | 525.87M | 482.88M | 478.37M | 430.31M | 410.85M |
| EBITDA | 690.87M | 642.26M | 630.61M | 564.05M | 542.49M |
| EPS Basic | 0.16 | 0.14 | 0.14 | 0.14 | 0.13 |
| Normalized Basic EPS | 0.10 | 0.09 | 0.09 | 0.09 | 0.08 |
| EPS Diluted | 0.15 | 0.14 | 0.14 | 0.14 | 0.13 |
| Normalized Diluted EPS | 0.10 | 0.09 | 0.09 | 0.08 | 0.08 |
| Average Basic Shares Outstanding | 6.52B | 6.56B | 6.59B | 6.72B | 6.72B |
| Average Diluted Shares Outstanding | 6.62B | 6.65B | 6.64B | 6.77B | 6.77B |
| Dividend Per Share | 0.05 | 0.06 | 0.07 | 0.04 | 0.05 |
| Payout Ratio | 44.33% | 50.11% | 50.54% | 39.94% | 44.30% |